市場調査レポート

商品コード

1663905

ヘリコバクター・ピロリ菌診断薬の市場規模、シェア、成長分析：検査タイプ別、方法別、エンドユーザー別、地域別 - 産業予測 2025～2032年

Helicobacter pylori H. pylori Diagnostics Market Size, Share, and Growth Analysis, By Test Type (Invasive, Histology), By Method (Immunoassays, Molecular diagnostics), By End User, By Region - Industry Forecast 2025-2032

出版日: 2025年02月22日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 760,921円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 890,134円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,019,347円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
目次

概要

サンプル依頼リストに入れる

ヘリコバクター・ピロリ菌診断薬の世界市場規模は、2023年に6億3,120万米ドルと評価され、2024年の6億7,475万米ドルから2032年には11億5,071万米ドルに成長し、予測期間（2025～2032年）のCAGRは6.9％で成長する見通しです。

ピロリ菌診断薬市場は、疾病管理の強化やヘルスケアコスト削減のための早期発見の重要性が高まっていることを背景に、牽引力を増しています。血液検査、呼気検査、便中抗原検査などの診断検査により、ピロリ菌感染の正確な同定が可能となり、患者の転帰改善につながるタイムリーな介入が促進されます。早期治療は症状を緩和し、潰瘍の治癒を早め、胃がんのような重篤な合併症を回避することができます。非侵襲的で費用対効果の高い検査オプションが利用可能になったことで、より幅広い患者層がアクセスしやすくなりました。さらに、治療法には、症状を緩和するだけでなく消化性潰瘍のリスクを軽減し、最終的には患者のQOLを向上させる様々な効果的な抗生物質や胃酸分泌抑制薬があります。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022～2024年）

主要企業プロファイル

Thermo Fisher Scientific（USA）
Bio-Rad Laboratories（USA）
Meridian Bioscience（USA）
F. Hoffmann-La Roche Ltd.（Switzerland）
Quest Diagnostics Incorporated（USA）
Abbott Laboratories（USA）
BioMerieux SA（France）
Cardinal Health, Inc.（USA）
Epitope Diagnostics, Inc.（USA）
Biohit Oyj（Finland）
Avanos Medical, Inc.（USA）
Quidel Corporation（USA）
DiaSorin S.p.A.（Italy）
Agilent Technologies, Inc.（USA）
Laboratory Corporation of America Holdings（LabCorp）（USA）
Siemens Healthineers AG（Germany）

結論と提言

Product Code: SQMIG35A2188

Global Helicobacter pylori H. pylori Diagnostics Market size was valued at USD 631.2 million in 2023 and is poised to grow from USD 674.75 million in 2024 to USD 1150.71 million by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).

The H. pylori diagnostics market is gaining traction, driven by the rising importance of early detection for enhanced disease management and reduced healthcare costs. Diagnostic tests such as blood, breath, and stool antigen tests enable accurate identification of H. pylori infections, facilitating timely intervention that leads to improved patient outcomes. Early treatment can alleviate symptoms, expedite ulcer healing, and avert severe complications like stomach cancer. The availability of non-invasive and cost-effective testing options increases accessibility for a broader patient population. Moreover, the treatment landscape includes a variety of effective antibiotics and acid-reducing medications that not only alleviate symptoms but also mitigate the risk of peptic ulcers, ultimately enhancing patients' quality of life.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Helicobacter Pylori H. Pylori Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Helicobacter Pylori H. Pylori Diagnostics Market Segments Analysis

Global Helicobacter pylori H. pylori Diagnostics Market is segmented by Test Type, Method, End User and region. Based on Test Type, the market is segmented into Invasive, Histology, Rapid Urease Test, HP Culture, Non-Invasive, Serologic Test, Urea Breath Test and Stool Antigen Test. Based on Method, the market is segmented into Immunoassays, Molecular diagnostics, Point of Care (POC) and Others. Based on End User, the market is segmented into Hospitals, Clinics, Diagnostic Labs and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Helicobacter Pylori H. Pylori Diagnostics Market

The global market for H. pylori diagnostics is primarily driven by the high prevalence of H. pylori infections worldwide, affecting nearly half of the global population. This widespread occurrence of one of the most prevalent bacterial infections has led to an increased demand for reliable diagnostic tests and effective treatment solutions. Healthcare professionals and patients alike are recognizing the necessity of accurate diagnosis to mitigate health complications associated with the infection. Consequently, the growing awareness and focus on managing H. pylori infections are propelling the market forward, emphasizing the need for innovative diagnostic tools and therapies to address this public health challenge.

Restraints in the Global Helicobacter Pylori H. Pylori Diagnostics Market

The expansion of the global Helicobacter pylori diagnostics market may face challenges due to the inadequate availability of healthcare resources and diagnostic tools, particularly in developing nations. Diagnosing and treating H. pylori infections typically requires specialized equipment and medical skills that may not be readily accessible in some areas. This lack of resources can significantly hinder market growth, as patients in these regions may struggle to obtain the necessary medical care. Consequently, the overall progress of H. pylori infection management could be stunted, limiting the market's potential to thrive and impacting patient outcomes in affected populations.

Market Trends of the Global Helicobacter Pylori H. Pylori Diagnostics Market

The Global Helicobacter Pylori (H. pylori) diagnostics market is experiencing a significant upward trend, primarily driven by a growing preference for non-invasive diagnostic methods, including serology tests and urea breath tests. This shift is fueled by increasing awareness of H. pylori's role in gastrointestinal diseases and the rising incidence of related conditions such as peptic ulcers and gastric cancer. The convenience and comfort of these minimally invasive tests are propelling their adoption among healthcare providers and patients alike. Additionally, advancements in technology and the integration of rapid testing options are further enhancing market growth, positioning non-invasive diagnostics as the preferred choice in H. pylori detection.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Helicobacter pylori H. pylori Diagnostics Market Size by Test Type & CAGR (2025-2032)

Market Overview
Invasive
Histology
Rapid Urease Test
HP Culture
Non-Invasive
Serologic Test
Urea Breath Test
Stool Antigen Test

Global Helicobacter pylori H. pylori Diagnostics Market Size by Method & CAGR (2025-2032)

Market Overview
Immunoassays
Molecular diagnostics
Point of Care (POC)
Others

Global Helicobacter pylori H. pylori Diagnostics Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals
Clinics
Diagnostic Labs
Others

Global Helicobacter pylori H. pylori Diagnostics Market Size & CAGR (2025-2032)

North America (Test Type, Method, End User)
- US
- Canada
Europe (Test Type, Method, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Test Type, Method, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Test Type, Method, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Test Type, Method, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meridian Bioscience (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics Incorporated (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Epitope Diagnostics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biohit Oyj (Finland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Avanos Medical, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quidel Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaSorin S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratory Corporation of America Holdings (LabCorp) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

ヘリコバクター・ピロリ菌診断薬の市場規模、シェア、成長分析：検査タイプ別、方法別、エンドユーザー別、地域別 - 産業予測 2025～2032年

Helicobacter pylori H. pylori Diagnostics Market Size, Share, and Growth Analysis, By Test Type (Invasive, Histology), By Method (Immunoassays, Molecular diagnostics), By End User, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

ヘリコバクター・ピロリ菌診断薬市場規模：検査タイプ別

ヘリコバクター・ピロリ菌診断薬市場規模：方法別

ヘリコバクター・ピロリ菌診断薬市場規模：エンドユーザー別

ヘリコバクター・ピロリ菌診断薬市場規模